RecruitingNCT00230685

Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia

Hammersmith Hospital Patients With Pulmonary Arteriovenous Malformations (PAVMs) and Hereditary Haemorrhagic Telangiectasia

Sponsor

Imperial College London

Enrollment

2,000 participants

Start Date

Jan 1, 2000

Study Type

OBSERVATIONAL

Conditions

Telangiectasia, Hereditary Hemorrhagic

Summary

This observational study is for individuals with Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations that are reviewed at the Hammersmith Hospital, London.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with telangiectasia, hereditary hemorrhagic. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Respiratory Medicine, Hammersmith Hospital

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00230685

Related Trials

Efficacy of Nintedanib for Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Patients

NCT049760363 locations

Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families

NCT002306201 location